Physician profile
Chady Atallah
NPI 1558637025
$4,403.27
in general payments reported to CMS, 2019-2025
10 companies · $77.85 in 2025
The $77.85 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,797 · 2021: $1,528 · 2022: $262 · 2023: $470 · 2024: $269 · 2025: $77.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,778.99 | 2021-2025 | Signia, Gia |
| Intuitive Surgical, INC. | $1,605.32 | 2019-2022 | |
| Integra Lifesciences Corporation | $223.43 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Becton, Dickinson and Company | $207.94 | 2024 | Phasix Mesh |
| Davol INC. | $206.91 | 2023 | Phasix Mesh |
| Tei Biosciences INC | $155.13 | 2019 | |
| Allergan, INC. | $133.09 | 2019 | |
| Ethicon US, LLC | $41.32 | 2025 | Enseal |
| Tela Bio, INC. | $36.74 | 2024 | Ovitex 2s |
| Takeda Pharmaceuticals U.S.A., INC. | $14.40 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chady Atallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.